<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://icrpaedia.org/index.php?action=history&amp;feed=atom&amp;title=Hyperfractionation</id>
	<title>Hyperfractionation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://icrpaedia.org/index.php?action=history&amp;feed=atom&amp;title=Hyperfractionation"/>
	<link rel="alternate" type="text/html" href="http://icrpaedia.org/index.php?title=Hyperfractionation&amp;action=history"/>
	<updated>2026-04-30T02:15:06Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://icrpaedia.org/index.php?title=Hyperfractionation&amp;diff=3009&amp;oldid=prev</id>
		<title>Chris Clement at 16:45, 12 August 2021</title>
		<link rel="alternate" type="text/html" href="http://icrpaedia.org/index.php?title=Hyperfractionation&amp;diff=3009&amp;oldid=prev"/>
		<updated>2021-08-12T16:45:45Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 16:45, 12 August 2021&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Glossary Icon-2.png|100px|frameless|right|link=ICRP Glossary]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Glossary Icon-2.png|100px|frameless|right|link=ICRP Glossary]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Significant reduction in dose per fraction below a conventional level of 1.8–2.0 Gy to give a greater total dose in a conventional overall treatment time. Different from &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;'&lt;/del&gt;accelerated fractionation&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;' &lt;/del&gt;where a conventional number of dose fractions is delivered in a significantly shortened overall treatment time in order to reduce the opportunity for tumor cell regeneration during treatment.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Significant reduction in dose per fraction below a conventional level of 1.8–2.0 Gy to give a greater total dose in a conventional overall treatment time. Different from &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[[&lt;/ins&gt;accelerated fractionation&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;]] &lt;/ins&gt;where a conventional number of dose fractions is delivered in a significantly shortened overall treatment time in order to reduce the opportunity for tumor cell regeneration during treatment.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''Return to [[ICRP Glossary|Glossary]]'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''Return to [[ICRP Glossary|Glossary]]'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Chris Clement</name></author>
		
	</entry>
	<entry>
		<id>http://icrpaedia.org/index.php?title=Hyperfractionation&amp;diff=3007&amp;oldid=prev</id>
		<title>Chris Clement: Created page with &quot;link=ICRP Glossary Significant reduction in dose per fraction below a conventional level of 1.8–2.0 Gy to give a greater t...&quot;</title>
		<link rel="alternate" type="text/html" href="http://icrpaedia.org/index.php?title=Hyperfractionation&amp;diff=3007&amp;oldid=prev"/>
		<updated>2021-08-12T16:44:52Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&lt;a href=&quot;/File:Glossary_Icon-2.png&quot; title=&quot;File:Glossary Icon-2.png&quot;&gt;100px|frameless|right|link=ICRP Glossary&lt;/a&gt; Significant reduction in dose per fraction below a conventional level of 1.8–2.0 Gy to give a greater t...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Glossary Icon-2.png|100px|frameless|right|link=ICRP Glossary]]&lt;br /&gt;
Significant reduction in dose per fraction below a conventional level of 1.8–2.0 Gy to give a greater total dose in a conventional overall treatment time. Different from 'accelerated fractionation' where a conventional number of dose fractions is delivered in a significantly shortened overall treatment time in order to reduce the opportunity for tumor cell regeneration during treatment.&lt;br /&gt;
&lt;br /&gt;
'''Return to [[ICRP Glossary|Glossary]]'''&lt;/div&gt;</summary>
		<author><name>Chris Clement</name></author>
		
	</entry>
</feed>